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DISCUSSION 
GREEN : Can you find and isolate this factor (IDS) in human periph-
eral blood T cells? 
JEGASOTHY : We can ma ke it us ing Con A as a stimulant. 
TURK: Have you looked at the effect of cyclophosphamide treatment 
on your system in rats? 
JEGASOTHY: No we have not. You can sublethally irradiate these 
animals and still get the suppressive effect in these ce lls. 
ScHILTZ: Will you comment on the tissue and species specificity of 
IDS? 
JEGASOTHY: It works on lymph node cells. It also works on L cells 
which ru·e transformed mouse fibroblasts. 
IMMUNOSUPPRESSIVE LYMPHOCYTE FACTORS 275 
ScHILTZ: You have tagged IDS as an inhibi tor of DNA synth esis. 
Can you in fact differentiate whether th e materia l inhibi ts DNA syn-
thesis (perhaps directly) or whether it is an inhibitor of replication, for 
which DNA synthesis is merely a measured end point? Will IDS inhibit 
DNA synthesis in vitro with DNA template, triphosphates, enzymes, 
etc? 
JEGASOTHY: We have measured the amou nt of DNA in th e cells t hat 
ar e treated with IDS a nd the amount of DNA decreased. The amount 
of DNA is the same as in unstimulated lymphocytes. 
BYSTRYN: Since your factor nonspecifically suppresses proliferation, 
do you think that conceptually it can be looked upon as a cha lone of 
lymphoid tissue? 
JEGASOTHY: You know we h ave talked about chalone being a sup-
pressive factor. We have tried to find this factor from other ce ll types, 
stimulating other cell types, getting it from epidermal homogenates 
and we cannot find the same factor. 
BRODY: Is this factor which you feel is responsible for an t igenic 
competition only locally active or can it be active systemically? We 
found, in the 60's, that antigenic competition was an entire ly localized 
phenomenon. 
JEGASOTHY: I think that looking at serum factors is very difficult in 
th e first place. I have done the same experiment you ta lked about a nd 
I cannot detect a circulat ing factor by the means we now have. 
BERMAN: Was the anti-in terferon antiserum you used anti-" immune" 
interferon or anti-"viral" in terferon? 
JEGASOTHY: We used both a nti-immune interferon and antiviral 
interferon. 
GIGLI: One wonders if this factor may bind to the ly mphocyte 
membra ne; therefore, it will no t be found in the ciTculation. 
JEGASOTHY: I think that is a great explanation a nd I think that is 
one of the reasons why many of the circulating factors cannot be 
actually found in serum. 
CLAMAN: What is the relation of IDS to blastogenic factoT? They are 
both made by activated T cells. 
JEGASOTHY: We find that the IDS comes off at a differen t fraction 
than blastogenic or mitogenic fac tors do and we aTe able to sep1p·ate 
out IDS pretty well. 
Announcement 
The Xlth International Pigment Cell Conference will be held in Sendai, Japan, Oct. 14-17, 1980. The 
scientific sessions will be comprised of special lectures, symposia and workshops on pigment cell biology 
and human and animal diseases of pigment cells including malignant melanoma and leukoderma (vitiligo). 
Full details may be obtained .by writing to Professox Makoto Seiji, Department of Dermatology, Tohoku 
University, Sendai, Japan. As in the previous 10 International Pigment Cell Conferences, there will be a 
multidisciplinary approach and pru·ticipation will include biochemists, cell biologists, basic medical 
investigators and biophysicists. 
